Prestige Consumer Healthcare
PBH
#4763
Rank
NZ$3.85 B
Marketcap
NZ$81.33
Share price
-1.97%
Change (1 day)
-22.64%
Change (1 year)

Earnings for Prestige Consumer Healthcare (PBH)

Earnings in 2026 (TTM): NZ$0.43 Billion

According to Prestige Consumer Healthcare's latest financial reports the company's current earnings are NZ$1.08 Billion. In 2025 the company made an earning of NZ$0.46 Billion a decrease over its 2024 earnings that were of NZ$0.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Prestige Consumer Healthcare from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.43 B-5.32%
2025 NZ$0.46 B-3.92%
2024 NZ$0.48 B-405.61%
2023 -NZ$0.16 Billion-134.07%
2022 NZ$0.46 B10.21%
2021 NZ$0.42 B12.88%
2020 NZ$0.37 B-657.8%
2019 -NZ$66.93 Million-143.45%
2018 NZ$0.15 B-50.46%
2017 NZ$0.31 B52.98%
2016 NZ$0.20 B-31.39%
2015 NZ$0.29 B45.68%
2014 NZ$0.20 B10.59%
2013 NZ$0.18 B38.24%
2012 NZ$0.13 B8.79%
2011 NZ$0.12 B55.18%
2010 NZ$78.78 M-123.77%
2009 -NZ$0.34 Billion-446.47%
2008 NZ$95.67 M8.03%
2007 NZ$88.56 M-3.71%
2006 NZ$91.97 M42.33%
2005 NZ$64.61 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$45.26 B 9,989.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
NZ$38.01 B 8,372.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.50 B 6,029.80%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$18.45 B 4,013.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$14.17 B 3,060.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
NZ$1.72 B 283.70%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
NZ$11.43 B 2,449.55%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$17.44 B 3,787.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
-NZ$2.43 Billion-640.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
NZ$76.18 M-83.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel